Acute Otitis Media: Adjuvant Therapy to Improve Outcome

Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000363
Collaborator
(none)
1

Study Details

Study Description

Brief Summary

Acute otitis media is one of the most common diseases of childhood and is one of the major causes of hearing loss in children. Despite the availability of effective antibiotic therapy for otitis media, treatment failures, persistent effusions, and recurrences are common. This Phase III outpatient study aims to test whether adjuvant therapy (an antihistamine or a corticosteroid), in addition to antibiotic therapy, improves the acute and long-term outcomes of patients with acute otitis media. This study is targeted to recruiting 200 infants (age less than one year); patient (and parent) participation is estimated to continue for one year after enrollment.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Masking:
Double
Primary Purpose:
Treatment
Study Completion Date :
Jun 1, 2001

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Months to 1 Year
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Have had two documented prior episodes of acute otitis media.

    • Have no current middle ear effusion (fluid).

    Exclusion Criteria:
    • Have chronic otitis media.

    • Have acute otitis media in addition to chronic otitis media.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Univ of Texas Med Branch Children's Hosp Galveston Texas United States 77550

    Sponsors and Collaborators

    • National Institute on Deafness and Other Communication Disorders (NIDCD)

    Investigators

    • Study Chair: Dr. Tasnee Chonmaitree,

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00000363
    Other Study ID Numbers:
    • NIDCD-1160
    • R01DC002620-04
    First Posted:
    Nov 3, 1999
    Last Update Posted:
    Apr 24, 2006
    Last Verified:
    Apr 1, 2006

    Study Results

    No Results Posted as of Apr 24, 2006